Suppr超能文献

加拿大开展的一项调查,旨在确定新发现的未经治疗的肺结核患者及复治病例中对异烟肼、对氨基水杨酸和链霉素的耐药率。

Canadian survey to determine the rate of drug resistance to isoniazid, PAS and streptomycin in newly detected untreated tuberculosis patients and retreatment cases.

作者信息

Hershfield E S, Eidus L, Helbecque D M

出版信息

Int J Clin Pharmacol Biopharm. 1979 Sep;17(9):387-93.

PMID:115802
Abstract

In 1975, a survey was carried out in Canada to determine the primary and acquired drug resistance of M. tuberculosis isolates to isoniazid (INH), para-aminosalicylic acid (PAS) and streptomycin. The results of this investigation were compared with those of the primary drug resistant study of Armstrong, undertaken in 1963-64. It revealed that primary drug resistance has increased from 4.9% to 6.3%. The increase is mainly due to immigrants having arrived in this country during the last 12 years. In these newcomers the primary resistance rate was 11.5%. Moreover, 57.8% of the immigrants examined in the survey were of Asian origin, with a drug resistance rate of 11.7%, while 15.6% had arrived from South Europe with a resistant ratio of 16.7%. In retreatment cases, the national average of drug resistance was 26.4%. Among the Canadian provinces, the highest drug resistance rate in retreatment patients (40%) was found in Quebec. While in primary resistance Streptomycin exhibited the highest incidence, in retreatment cases isoniazid resistance proved to be more frequent. In natives, the rates and patterns of primary and acquired resistance were very similar to those observed in other Canadian born patients.

摘要

1975年,加拿大开展了一项调查,以确定结核分枝杆菌分离株对异烟肼(INH)、对氨基水杨酸(PAS)和链霉素的原发及获得性耐药情况。该调查结果与1963 - 1964年阿姆斯特朗进行的原发耐药性研究结果进行了比较。结果显示,原发耐药性已从4.9%增至6.3%。这种增长主要归因于过去12年抵达该国的移民。在这些新移民中,原发耐药率为11.5%。此外,调查中接受检查的移民有57.8%来自亚洲,耐药率为11.7%,而15.6%来自南欧,耐药率为16.7%。在复治病例中,全国平均耐药率为26.4%。在加拿大各省中,魁北克复治患者的耐药率最高(40%)。在原发耐药中,链霉素的发生率最高,而在复治病例中,异烟肼耐药更为常见。在本地人中,原发和获得性耐药的发生率及模式与其他加拿大出生患者中观察到的情况非常相似。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验